In line with our findings, previous case series have shown elevated levels of IgG4 in 9%-27% of PSC patients.19–23,27 However, the number of included patients varied widely (34-285) and serum IgG1, IgG2, and IgG3 levels were never reported. The gene discussed is IGHG3; the disease is pancreatic serous cystadenoma.